期刊文献+

白血病形成中JAK/STAT信号通路的持续激活 被引量:6

Constitutive activation of JAK/STAT signaling pathway in leukemogenesis
下载PDF
导出
摘要 JAK/STAT通路是细胞因子、生长因子、激素等广泛应用的信号转导通路,白血病形成中普遍存在JAK/STAT通路的持续激活。白血病融合蛋白的表达、酪氨酸激酶过度表达或激活突变及某些病毒感染可导致JAK/STAT通路的持续激活和调节异常,并引起细胞的转化和白血病形成。了解白血病形成中JAK/STAT通路的异常调节有助于开发靶向JAK/STAT通路的治疗策略。 The JAK/STAT pathway that contributes to signal transduction by cytoklnes, growm factors and hormones is universally activated in leukemias. Leukemogenesis is frequently associated with the aberrant expression of activated fusion tyrosine kinases or activated protein tyrosine kinases carrying mutations. The activated kinase enzymes result in continuative activation of JAK/STAT signaling pathway. Furthermore, some virus infections are associated with dysregulation of JAK/STAT pathway. The dysregnlation of JAK/STAT pathway contributes to cellular malignant transformation and leukemogenesis. A better understanding of mechanisms of the dysregulation of JAK/STAT signaling pathway may serve as a basis for designing novel therapeutic strategies that target these pathway in leukemia cells.
出处 《国际病理科学与临床杂志》 CAS 2006年第5期398-402,共5页 Journal of International Pathology and Clinical Medicine
关键词 JAK/STAT 信号通路 持续激活 白血病形成 JAK/STAT signaling pathway consititutive activation leukemogenesis
  • 相关文献

参考文献29

  • 1Rawlings J S, Rosier K M, Harrison D A. The JAK/STAT signaling pathway[J]. J Cell Sci, 2004, 117( Pt 8) :1281-1283. 被引量:1
  • 2Benekli M, Baer M R, Baumann H, et al. Signal transducer and activator of transcription proteins in leukemias [ J ]. Blood, 2003,101 (8) :2940-2954. 被引量:1
  • 3Steinberg D W, Gilliland D G. The role of signal transducer and activator of transcription factors in leukemogenesis [ J ]. J C lin Oncol, 2004, 22(2) :361-371. 被引量:1
  • 4Yamaoka K, Saharinen P, Pesu M, et al. The Janus kinases(Jaks) [J]. Genome Biol, 2004,5(12) :253. 被引量:1
  • 5Hendry L, John S. Regulation of STAT signalling by proteolytic processing[J]. Eur J Biochem, 2004, 271 (23-24):4613-4620. 被引量:1
  • 6Wormald S, Hilton D J. lnhibitors of cytokine signal transduction[J]. J Biol Chem, 2004,279(2) :821-824. 被引量:1
  • 7Frantsve J, Schwaller J, Steinberg D W, et al. SOCS-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through Inhibition of JAK2 kinase activity and induction of proteasome mediated degradation[J]. Mol Cell Biol, 2001,21 (10) :3547-3557. 被引量:1
  • 8Schwaller J, Frantsve J, Aster J , et al. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myeloid and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion gene[J]. EMBO J, 1998,17(18) :5321-5333. 被引量:1
  • 9Carron C, Cormier F, Janin A, et al. TEL-JAK2 transgenic mice develop T-cell leukemia [ J ]. Blood, 2000,95:3891-3899. 被引量:1
  • 10Kamizono S, Hanada T, Yasukawa H, et al. The SOCS Box of SOCS-1 Accelerates Ubiquitin-dependent Proteolysis of TEL-JAK2[J]. J Biol Chem, 2001,276(16) :12530-12538. 被引量:1

同被引文献92

  • 1陈伟红,陈燕,崔国惠,谷俊侠,胡东,陈维凯,李新刚.姜黄素在CML原代细胞STAT5信号途径中的作用[J].中国实验血液学杂志,2004,12(5):572-576. 被引量:2
  • 2韩颖,罗建民,贾晓辉,王福旭,姚丽,杜行严.白血病患者造血细胞磷酸酶与半胱氨酸蛋白酶基因表达及其临床意义[J].中华内科杂志,2006,45(5):363-365. 被引量:18
  • 3Warmuth M,Danhauser-Riedl S,Hallek M.Molecular pathogenesis of chronic myeloid leukemia:implications for new therapeutic strategies[J].Ann Hematol,1999,78(2):49-64. 被引量:1
  • 4Fei F,Stoddart S,Müschen M,et al.Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia[J].Leukemia,2010,24(4):813-820. 被引量:1
  • 5Zheng X,Oancea C,Henschler R,et al.Reciprocal t(9;22) ABL/BCR fusion proteins:leukemogenic potential and effects on B cell Commitment[J].PLoS One,2009,4(10):e7661. 被引量:1
  • 6Manley P W,Cowan-Jacob S W,Mestan J,et al.Advances in the structural biology,design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia[J].Biochim Biophys Acta,2005,1754(1-2):3-13. 被引量:1
  • 7Pluk H,Dorey K,Superti-Furga G.Autoinhibition of c-Abl[J].Cell,2002,108(2):247-259. 被引量:1
  • 8Gu J J,Ryu J R,Pendergast A M.Abl tyrosine kinases in T-cell signaling[J].Immunological Reviews,2009,228:170-183. 被引量:1
  • 9Nagar B,Hantschel O,Young M A,et al.Structure basis for the autoinhibition of c-abl tyrosine kinase[J].Cell,2003,112(6):859-871. 被引量:1
  • 10Sawyers C L.Disabling Abl-Perspectives on Abl kinase regulation and cancer therapeutics[J].Cancer Cell,2002,1(1):13-15. 被引量:1

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部